Lilia Shwartsman

Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation.

Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation.

Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation.

Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation.

Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation.